BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 91 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,792,000 | +97.3% | 20,096 | -37.8% | 0.14% | +42.9% |
| Q2 2019 | $1,415,000 | -55.0% | 32,300 | -47.1% | 0.10% | -44.6% |
| Q1 2019 | $3,143,000 | -22.7% | 61,069 | -44.5% | 0.18% | -43.5% |
| Q4 2018 | $4,068,000 | +18.4% | 110,010 | +20.2% | 0.31% | +29.9% |
| Q3 2018 | $3,436,000 | -32.8% | 91,488 | -29.3% | 0.24% | -8.7% |
| Q2 2018 | $5,113,000 | +77.2% | 129,368 | +15.5% | 0.26% | +114.6% |
| Q1 2018 | $2,885,000 | +31.2% | 111,991 | +37.4% | 0.12% | +7.0% |
| Q4 2017 | $2,199,000 | – | 81,497 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |